4.8 Article

Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread

Journal

CANCER CELL
Volume 26, Issue 1, Pages 77-91

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2014.05.002

Keywords

-

Funding

  1. Ovarian Cancer Research Fund, Inc.
  2. Foundation for Women's Cancer
  3. Cancer Prevention Research Institute Texas (CPRIT) training grants [RP101502, RP101489]
  4. NIH T32 Training Grant [CA101642]
  5. Ann Schreiber Program for Excellence grant from the Ovarian Cancer Research Foundation
  6. Marsha Rivkin Center for Ovarian Cancer Research
  7. NIH [P50CA083639, CA109298, P50CA098258, CA177909, U54CA151668, UH2TR000943, CA016672, U54CA96300, U54CA96297]
  8. CPRIT [RP110595, RP120214]
  9. Ovarian Cancer Research Fund Program Project Development Grant
  10. Department of Defense [OC120547, OC093416]
  11. Betty Ann Asche Murray Distinguished Professorship
  12. Marcus Foundation
  13. RGK Foundation
  14. Gilder Foundation
  15. Judi A. Rees Ovarian Cancer Research Fund
  16. Chapman Foundation
  17. Meyer and Ida Gordon Foundation
  18. Ann Rife Cox Chair in Gynecology
  19. Blanton-Davis Ovarian Cancer Research Program
  20. Small Animal Imaging Facility

Ask authors/readers for more resources

Ovarian cancer has a clear predilection for metastasis to the omentum, but the underlying mechanisms involved in ovarian cancer spread are not well understood. Here, we used a parabiosis model that demonstrates preferential hematogenous metastasis of ovarian cancer to the omentum. Our studies revealed that the ErbB3-neuregulin 1 (NRG1) axis is a dominant pathway responsible for hematogenous omental metastasis. Elevated levels of ErbB3 in ovarian cancer cells and NRG1 in the omentum allowed for tumor cell localization and growth in the omentum. Depletion of ErbB3 in ovarian cancer impaired omental metastasis. Our results highlight hematogenous metastasis as an important mode of ovarian cancer metastasis. These findings have implications for designing alternative strategies aimed at preventing and treating ovarian cancer metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available